REDWOOD CITY, Calif. — Genapsys, Inc. (Genapsys), a company developing a highly accurate and scalable electronic sequencing platform, today announced the additions of Priya Ray and Peter Swider to the Company’s leadership team as well as the launch of the company’s new branding and corporate website, www.genapsys.com. “We are pleased to welcome Priya and Peter […]
Seattle, WA – RareCyte, Inc. (“RareCyte” or “the Company”) a Life Sciences company developing and manufacturing proprietary platforms enabling precision biology solutions, announced today the completion of a $24M financing from new and existing investors. The funding will drive the commercialization and applications for the Company’s new Orion spatial biology platform and further global expansion […]
Three new manufacturing lines were successfully launched in under ten months, with an additional eight new lines planned to launch in Q3 2022. Sustain and secure the supply chain for customers in China and the broader region. With the use of Fortem™ film, Cytiva helps customers speed up their clinical manufacturing and product launches; improve manufacturing […]
– Research collaboration covers multiple antibody research programs – SOUTH SAN FRANCISCO, Calif. & INGELHEIM, Germany — Twist Bioscience Corporation (NASDAQ:TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced a broad-based research collaboration with Boehringer Ingelheim International GmbH to use Twist’s proprietary antibody libraries […]
SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN) elevates climate action goals with commitments for net zero greenhouse gas emissions aligned with the Paris Agreement, commits to verified Science Based Targets, signs the Business Ambition for 1.5 degree and joins the United Nations campaign Race to Zero. “Human health and the health of our environment are intertwined. At Illumina, […]
Kadia joins Board as an Independent Director who brings significant expertise in commercializing disruptive life science technologies EMERYVILLE, Calif. — Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced that Siddhartha Kadia, Ph.D. joined the Berkeley Lights Board of Directors as an independent director, effective September 7, 2021. “I am excited […]
SAN DIEGO — Aviva Systems Biology, a market leader in antibodies, immunoassay kits, and recombinant proteins for life science research, today announced the launch of its new Protein on Demand™ semi-custom recombinant protein portfolio for life scientists conducting basic research and preclinical studies. The Protein on Demand portfolio of over 300,000 proteins enables rapid access to […]
ROSEMONT, Ill. — Proteintech Group, an original manufacturer of antibodies, nanobodies and recombinant proteins, today announced that it has made a strategic investment in Active Motif, a life science tools company focused on bringing epigenetics into the translational and precision medicine segments. The companies did not disclose any financial details about the transaction. Active Motif […]
CHICAGO — Bringing an added level of confidence to the robust science that its assay offers, the bioMérieux, Inc. GENE-UP® NUTRAPLEX PRO™ multiplex pathogen detection assay has achieved the AOAC® Research Institute Performance Tested MethodsSM approval (PTM 082103). AOAC validation demonstrated statistical equiavalence to the U.S. Food and Drug (FDA) and U. S. Pharmacopeia (USP) reference methods for the detection […]
NEW YORK — Biotia, Inc., a company that delivers proprietary analytical software for infectious disease diagnostics, is experiencing rapid adoption by clinical researchers worldwide of its user-friendly software platform for the comprehensive surveillance and deeper insights into COVID-19 viral genetic variants. Biotia’s COVID-DX software has been optimized for researchers sequencing COVID-19 clinical specimens and wastewater samples using the popular […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
